G Nowak

1.3k total citations
58 papers, 1.0k citations indexed

About

G Nowak is a scholar working on Hematology, Surgery and Molecular Biology. According to data from OpenAlex, G Nowak has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 20 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in G Nowak's work include Blood Coagulation and Thrombosis Mechanisms (20 papers), Heparin-Induced Thrombocytopenia and Thrombosis (19 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). G Nowak is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (20 papers), Heparin-Induced Thrombocytopenia and Thrombosis (19 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). G Nowak collaborates with scholars based in Germany, Czechia and United States. G Nowak's co-authors include F Markwárdt, Elke Bucha, Jörg Stürzebecher, P Walsmann, Brigitte Kaiser, G Vogel, Roland Kaufmann, J. Hauptmann, H.‐P. Klöcking and M. Richter and has published in prestigious journals such as British Journal of Cancer, British Journal of Pharmacology and Cellular and Molecular Life Sciences.

In The Last Decade

G Nowak

57 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Nowak Germany 18 416 411 330 263 174 58 1.0k
Mohamed Hatmi France 18 330 0.8× 132 0.3× 168 0.5× 231 0.9× 120 0.7× 39 978
Pradip K. Rustagi United States 14 241 0.6× 498 1.2× 355 1.1× 178 0.7× 73 0.4× 23 995
O.R. Ødegård Norway 13 620 1.5× 167 0.4× 178 0.5× 198 0.8× 51 0.3× 21 1.0k
J. N. Shanberge United States 16 321 0.8× 234 0.6× 98 0.3× 132 0.5× 27 0.2× 42 853
Stephan Schwers Germany 16 273 0.7× 71 0.2× 253 0.8× 386 1.5× 49 0.3× 30 1.2k
Junjie Kou China 21 199 0.5× 68 0.2× 97 0.3× 112 0.4× 52 0.3× 44 1.1k
Märta Knös Germany 7 200 0.5× 70 0.2× 36 0.1× 89 0.3× 43 0.2× 11 697
Tamyra Downs United States 14 224 0.5× 55 0.1× 40 0.1× 64 0.2× 101 0.6× 19 830
Binggang Xiang United States 11 298 0.7× 72 0.2× 43 0.1× 111 0.4× 25 0.1× 14 843
Antoni Stadnicki Poland 22 183 0.4× 172 0.4× 26 0.1× 30 0.1× 181 1.0× 43 818

Countries citing papers authored by G Nowak

Since Specialization
Citations

This map shows the geographic impact of G Nowak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Nowak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Nowak more than expected).

Fields of papers citing papers by G Nowak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Nowak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Nowak. The network helps show where G Nowak may publish in the future.

Co-authorship network of co-authors of G Nowak

This figure shows the co-authorship network connecting the top 25 collaborators of G Nowak. A scholar is included among the top collaborators of G Nowak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Nowak. G Nowak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erlacher, Miriam, Matthias Uhl, U. Budde, et al.. (2009). Lepirudin Treatment in a Girl with Iliac Vein Thrombosis, Severe Pulmonary Embolism and Suspected Heparin-induced Thrombocytopenia (HIT) II. Klinische Pädiatrie. 221(3). 174–175. 1 indexed citations
2.
Mende, Katrin, et al.. (2004). Three recombinant serine proteinase inhibitors expressed from the coding region of the thrombin inhibitor dipetalogastin. Insect Biochemistry and Molecular Biology. 34(9). 971–979. 13 indexed citations
3.
Mende, Katrin, et al.. (2003). Cloning, purification and biochemical characterization of dipetarudin, a new chimeric thrombin inhibitor. Journal of Chromatography B. 786(1-2). 73–80. 10 indexed citations
4.
Nowak, G, et al.. (2003). Ecarin Chromogenic Assay – A New Method for Quantitative Determination of Direct Thrombin Inhibitors Like Hirudin. Pathophysiology of Haemostasis and Thrombosis. 33(4). 184–191. 62 indexed citations
5.
Bretschneider, Ellen, Roland Kaufmann, Michael Braun, et al.. (2001). Evidence for functionally active protease‐activated receptor‐4 (PAR‐4) in human vascular smooth muscle cells. British Journal of Pharmacology. 132(7). 1441–1446. 45 indexed citations
6.
Sauer, Michelle, et al.. (2001). EVIDENCE FOR A NOVEL THROMBOPOIETIN SIGNALLING EVENT: ACTIVATION OF PROTEIN KINASE A IN HUMAN MEGAKARYOBLASTIC CMK CELLS. Cytokine. 15(2). 75–79. 7 indexed citations
7.
Kaufmann, Roland, Stephan Patt, Michael Zieger, et al.. (2000). The two-receptor system PAR-1/PAR-4 mediates α-thrombin-induced [Ca2+]i mobilization in human astrocytoma cells. Journal of Cancer Research and Clinical Oncology. 126(2). 91–94. 28 indexed citations
8.
Kaufmann, Roland, et al.. (1998). Protein kinase C is involved in cholecystokinin octapeptide-induced proliferative action in rat glioma C6 cells. Neuropeptides. 32(2). 185–189. 8 indexed citations
9.
Nowak, G, et al.. (1997). Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.. PubMed. 109(10). 354–8. 48 indexed citations
10.
Kaufmann, Roland, et al.. (1997). Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growth. Neuropeptides. 31(6). 573–583. 17 indexed citations
11.
Kaufmann, Roland, Carsten Lindschau, Ae‐Young Her, et al.. (1996). Signaling effects of ?-thrombin and SFLLRN in rat glioma C6 cells. Journal of Neuroscience Research. 46(6). 641–651. 10 indexed citations
12.
Nowak, G, et al.. (1992). Pharmacology of r-hirudin in renal impairment. Thrombosis Research. 66(6). 707–715. 66 indexed citations
13.
Nowak, G & Elke Bucha. (1992). Ecarin-induced meizothrombin formation — An efficient antidote of hirudin. Thrombosis Research. 65. S157–S157. 1 indexed citations
14.
Markwárdt, F, G Nowak, & Jörg Stürzebecher. (1991). Clinical Pharmacology of Recombinant Hirudin. Pathophysiology of Haemostasis and Thrombosis. 21(Suppl. 1). 133–136. 29 indexed citations
15.
Bucha, Elke, F Markwárdt, & G Nowak. (1990). Hirudin in haemodialysis. Thrombosis Research. 60(6). 445–455. 20 indexed citations
16.
Markwárdt, F, Brigitte Kaiser, & G Nowak. (1989). Studies on antithrombotic effects of recombinant hirudin. Thrombosis Research. 54(5). 377–388. 46 indexed citations
17.
Bekemeier, H, R Hirschelmann, Uwe Lange, & G Nowak. (1988). Strain-dependence of kappa-carrageenin thrombosis in rats and mice. Inflammation Research. 23(1-2). 108–109. 2 indexed citations
18.
Markwárdt, F, G Nowak, Jörg Stürzebecher, & G Vogel. (1988). Clinico-pharmacological studies with recombinant hirudin. Thrombosis Research. 52(5). 393–400. 54 indexed citations
19.
Hauptmann, J., et al.. (1978). Cardiac effects of 16-acetyl-gitoxin, the active glycoside after penta-acetyl-gitoxin administration.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(11-12). 1713–20. 1 indexed citations
20.
Markwárdt, F, et al.. (1975). Studies in Experimental Animals on Disseminated Intravascular Coagulation (DIC). Thrombosis and Haemostasis. 34(2). 513–521. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed Hatmi Breakdown of academic impact, for papers by Pradip K. Rustagi Breakdown of academic impact, for papers by O.R. Ødegård Breakdown of academic impact, for papers by J. N. Shanberge Breakdown of academic impact, for papers by Stephan Schwers Breakdown of academic impact, for papers by Junjie Kou Breakdown of academic impact, for papers by Märta Knös Breakdown of academic impact, for papers by Tamyra Downs Breakdown of academic impact, for papers by Binggang Xiang Breakdown of academic impact, for papers by Antoni Stadnicki
Rankless by CCL
2026